UL JENSEN HOLDING ApS — Credit Rating and Financial Key Figures
CVR number: 33638590
Furesøbakken 18 A, 3460 Birkerød
ulrikke.jensen@billevpharma.dk
tel: 42239260
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | -6.25 | -3.22 | -9.04 | -3.35 | -10.27 |
| EBIT | -6.25 | -3.22 | -9.04 | -3.35 | -10.27 |
| Other financial income | 45.62 | 97.80 | 179.36 | 362.64 | 277.78 |
| Other financial expenses | -3.22 | -32.69 | -3.65 | -0.83 | - 190.35 |
| Income from other inv. held as non-curr. assets | 3 872.22 | ||||
| Net income from associates (fin.) | 2 774.43 | 3 006.58 | 2 471.53 | 1 689.27 | 3 071.93 |
| Pre-tax profit | 2 810.58 | 3 068.47 | 2 638.19 | 2 047.73 | 7 021.31 |
| Income taxes | -30.02 | -81.37 | -17.15 | ||
| Net earnings | 2 810.58 | 3 068.47 | 2 608.17 | 1 966.37 | 7 004.15 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Participating interests | 2 934.43 | 3 166.58 | 2 631.53 | 1 849.27 | 3 231.93 |
| Investments total | 2 934.43 | 3 166.58 | 2 631.53 | 1 849.27 | 3 231.93 |
| Non-current loans receivable | 35.11 | 35.11 | 35.11 | 35.11 | |
| Long term receivables total | 35.11 | 35.11 | 35.11 | 35.11 | |
| Inventories total | |||||
| Current amounts owed by group member comp. | 0.74 | 7.69 | 800.00 | ||
| Current deferred tax assets | 20.71 | 47.27 | 91.14 | 125.20 | |
| Short term receivables total | 0.74 | 20.71 | 54.96 | 91.14 | 925.20 |
| Other current investments | 724.81 | 1 596.76 | 3 900.61 | 5 151.93 | 5 563.67 |
| Cash and bank deposits | 29.64 | 99.14 | 99.31 | 806.81 | 4 336.95 |
| Cash and cash equivalents | 754.46 | 1 695.90 | 3 999.92 | 5 958.74 | 9 900.62 |
| Balance sheet total (assets) | 3 724.73 | 4 918.30 | 6 721.52 | 7 934.26 | 14 057.75 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 80.00 | 80.00 | 80.00 | 80.00 | 80.00 |
| Shares repurchased | 1 875.00 | 835.00 | 835.00 | 835.00 | 1 689.38 |
| Other reserves | 2 328.86 | 1 521.78 | 2 929.26 | ||
| Retained earnings | -1 080.75 | 894.83 | 799.44 | 3 379.68 | 2 249.19 |
| Profit of the financial year | 2 810.58 | 3 068.47 | 2 608.17 | 1 966.37 | 7 004.15 |
| Shareholders equity total | 3 684.83 | 4 878.30 | 6 651.47 | 7 782.84 | 13 951.99 |
| Non-current deferred tax liabilities | 81.37 | 17.15 | |||
| Non-current liabilities total | 81.37 | 17.15 | |||
| Current trade creditors | 3.13 | 3.22 | 3.25 | 3.25 | 3.25 |
| Current owed to participating | 36.78 | 36.78 | 36.78 | 36.78 | |
| Short-term deferred tax liabilities | 30.02 | 30.02 | 81.37 | ||
| Other non-interest bearing current liabilities | 3.99 | ||||
| Current liabilities total | 39.91 | 40.00 | 70.06 | 70.06 | 88.61 |
| Balance sheet total (liabilities) | 3 724.73 | 4 918.30 | 6 721.52 | 7 934.26 | 14 057.75 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.